Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
or

Sarepta Therapeutics (SRPT)

Sarepta Therapeutics (SRPT)
52.70 x 1 55.00 x 3
Post-market by (Cboe BZX)
54.43 -4.18 (-7.13%) 04/04/25 [NASDAQ]
52.70 x 1 55.00 x 3
Post-market 54.78 +0.35 (+0.64%) 16:27 ET
Quote Overview for Fri, Apr 4th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
54.26
Day High
59.45
Open 59.22
Previous Close 58.61 58.61
Volume 4,574,647 4,574,647
Avg Vol 2,891,422 2,891,422
Stochastic %K 2.57% 2.57%
Weighted Alpha -67.17 -67.17
5-Day Change -16.02 (-22.75%) -16.02 (-22.75%)
52-Week Range 54.29 - 173.25 54.29 - 173.25
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 5,687,045
  • Shares Outstanding, K 97,032
  • Annual Sales, $ 1,902 M
  • Annual Income, $ 235,240 K
  • EBIT $ 220 M
  • EBITDA $ 218 M
  • 60-Month Beta 0.93
  • Price/Sales 3.19
  • Price/Cash Flow 25.64
  • Price/Book 3.91

Options Overview Details

View History
  • Implied Volatility 84.81% ( +8.69%)
  • Historical Volatility 107.17%
  • IV Percentile 88%
  • IV Rank 45.66%
  • IV High 147.45% on 05/29/24
  • IV Low 32.18% on 01/22/25
  • Put/Call Vol Ratio 0.36
  • Today's Volume 1,843
  • Volume Avg (30-Day) 4,763
  • Put/Call OI Ratio 0.64
  • Today's Open Interest 50,573
  • Open Int (30-Day) 38,312

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 22 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate 1.74
  • Number of Estimates 6
  • High Estimate 2.31
  • Low Estimate 1.50
  • Prior Year 0.38
  • Growth Rate Est. (year over year) +357.89%

Price Performance

See More
Period Period Low Period High Performance
1-Month
54.29 +0.18%
on 04/04/25
Period Open: 102.86
107.77 -49.53%
on 03/05/25
-48.47 (-47.12%)
since 03/04/25
3-Month
54.29 +0.18%
on 04/04/25
Period Open: 126.29
129.84 -58.11%
on 01/07/25
-71.90 (-56.93%)
since 01/03/25
52-Week
54.29 +0.18%
on 04/04/25
Period Open: 125.79
173.25 -68.61%
on 06/21/24
-71.40 (-56.76%)
since 04/04/24

Most Recent Stories

More News
Sarepta Therapeutics Temporarily Halts Three Clinical Studies Of Elevidys: Retail Is Dull While Stock Drops

H.C. Wainwright told investors in a research note that the clinical hold on key Elevidys trials in Europe heightens the uncertainty around the future of the franchise.

SRPT : 54.39 (-7.20%)
IJH : 52.88 (-4.87%)
VTI : 248.47 (-5.87%)
Q4 Earnings Outperformers: Amgen (NASDAQ:AMGN) And The Rest Of The Therapeutics Stocks

Q4 Earnings Outperformers: Amgen (NASDAQ:AMGN) And The Rest Of The Therapeutics Stocks

SRPT : 54.39 (-7.20%)
BMRN : 60.26 (-10.70%)
VRTX : 474.62 (-1.94%)
MRNA : 25.11 (-2.41%)
AMGN : 294.39 (-4.99%)
Equity Markets Recover on Strength in Defensive Stocks and Energy Producers

The S&P 500 Index ($SPX ) (SPY ) Monday closed up +0.55%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +1.00%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.02%. June E-mini S&P...

ALK : 44.45 (-3.24%)
IIPR : 53.43 (+1.93%)
MPC : 121.07 (-5.85%)
GOOGL : 145.60 (-3.40%)
AAPL : 188.38 (-7.29%)
HRL : 30.74 (-2.23%)
SRPT : 54.39 (-7.20%)
OXY : 40.54 (-7.65%)
TSLA : 239.43 (-10.42%)
FANG : 123.37 (-12.68%)
SPY : 505.28 (-5.85%)
AIG : 78.95 (-8.41%)
Why Sarepta Therapeutics (SRPT) Stock Is Nosediving

Why Sarepta Therapeutics (SRPT) Stock Is Nosediving

SRPT : 54.39 (-7.20%)
Stocks Mixed on Tariff Concerns

The S&P 500 Index ($SPX ) (SPY ) today is up +0.24%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.78%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.49%. After a lower open, stock indexes...

ALK : 44.45 (-3.24%)
IIPR : 53.43 (+1.93%)
GOOGL : 145.60 (-3.40%)
TAP : 61.15 (-2.10%)
HRL : 30.74 (-2.23%)
SRPT : 54.39 (-7.20%)
KHC : 29.68 (-3.67%)
TSLA : 239.43 (-10.42%)
KDP : 33.81 (-5.11%)
AMD : 85.76 (-8.57%)
SPY : 505.28 (-5.85%)
AIG : 78.95 (-8.41%)
Global Equity Markets Slide on US Tariff Concerns

The S&P 500 Index ($SPX ) (SPY ) today is down -1.54%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -1.00%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -2.30%. June E-mini S&P futures...

MSTR : 293.61 (+4.01%)
IIPR : 53.43 (+1.93%)
GOOGL : 145.60 (-3.40%)
AAPL : 188.38 (-7.29%)
HRL : 30.74 (-2.23%)
SRPT : 54.39 (-7.20%)
KHC : 29.68 (-3.67%)
COIN : 160.55 (-5.98%)
TSLA : 239.43 (-10.42%)
AMD : 85.76 (-8.57%)
SPY : 505.28 (-5.85%)
META : 504.73 (-5.06%)
Q4 Rundown: Moderna (NASDAQ:MRNA) Vs Other Therapeutics Stocks

Q4 Rundown: Moderna (NASDAQ:MRNA) Vs Other Therapeutics Stocks

SRPT : 54.39 (-7.20%)
BMRN : 60.26 (-10.70%)
ABBV : 186.96 (-7.28%)
MRNA : 25.11 (-2.41%)
BIIB : 122.98 (-5.91%)
Is This Stock a Buy After a Massive 20% Drop in 1 Day?

Things are going from bad to worse for Sarepta Therapeutics (NASDAQ: SRPT), a biotech focusing on gene therapies. The company's performance over the past six months had already been unimpressive. But on...

SRPT : 54.39 (-7.20%)
Q4 Earnings Review: Therapeutics Stocks Led by BioMarin Pharmaceutical (NASDAQ:BMRN)

Q4 Earnings Review: Therapeutics Stocks Led by BioMarin Pharmaceutical (NASDAQ:BMRN)

SRPT : 54.39 (-7.20%)
BMRN : 60.26 (-10.70%)
GILD : 107.25 (-4.57%)
MRNA : 25.11 (-2.41%)
AMGN : 294.39 (-4.99%)
Sarepta Therapeutics Stock Has A Nightmarish Week After DMD Patient Death, But Retail And Analysts Aren't Giving Up

Jefferies acknowledged acute liver failure could signal a new safety risk but maintained that the high unmet need for DMD treatments supports the bull case.

SRPT : 54.39 (-7.20%)
IJH : 52.88 (-4.87%)
VTI : 248.47 (-5.87%)
XBI : 73.66 (-5.73%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell and ranks in the Top 1% of all short term signal directions.

Long term indicators fully support a continuation of the trend.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Business Summary

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company that focuses on the discovery and development of RNA-based therapeutics targeting rare and infectious diseases. It concentrates on the development of exon-skipping drug candidates targeting Duchenne muscular dystrophy (DMD), a...

See More

Key Turning Points

3rd Resistance Point 63.29
2nd Resistance Point 61.76
1st Resistance Point 60.19
Last Price 54.39
1st Support Level 57.09
2nd Support Level 55.56
3rd Support Level 53.99

See More

52-Week High 173.25
Fibonacci 61.8% 127.81
Fibonacci 50% 113.77
Fibonacci 38.2% 99.73
Last Price 54.39
52-Week Low 54.29

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Trader's Cheat Sheet: Your Secret Weapon for Smarter Trades